Skip to contentC
Cerenome, Inc.
C
CNSYCerenome, Inc. Q2 2021 · 10-Q
Revenue—
Net Income-$2.80M-$2.80MN/M vs Q2 2020 EPS Diluted-$0.25-$0.25N/M vs Q2 2020 Operating Income-$2,575,000N/M Operating Cash Flowderived-$2,399,000N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cerenome, Inc. · CIK 1095981 · Engraved from SEC EDGAR
Free Cash Flowderived-$2,395,000N/M ended Jun 30, 2021 · filed Jul 22, 2021 · 22 d after period end